Association between Vitamin D Status and Premenstrual Symptoms

Published:September 01, 2018DOI:https://doi.org/10.1016/j.jand.2018.06.014

      Abstract

      Background

      Premenstrual symptoms are experienced by up to 95% of women, and few treatments are available. Previous studies suggest that 25-hydroxyvitamin D (25(OH)D) may be associated with the severity of premenstrual symptoms, but the findings have been inconclusive.

      Objective

      The objective of this study was to determine whether vitamin D status is associated with the severity of individual premenstrual symptoms.

      Design/participants

      Cross-sectional analysis of 998 women aged 20 to 29 years recruited at the University of Toronto campus from 2004 through 2010.

      Main outcome measures

      Participants provided data on their premenstrual symptoms in a premenstrual symptom questionnaire. Fasting overnight blood samples were collected, and plasma 25(OH)D was measured. Participants with plasma 25(OH)D concentrations <20 ng/mL were considered to have inadequate vitamin D status, and those with ≥20 ng/mL, adequate vitamin D status.

      Statistical analyses performed

      Multinomial logistic regressions were used to calculate the odds ratio (OR) and 95% confidence interval for the associations between vitamin D status and the severity of 15 premenstrual symptoms. Adjustments were made for age, body mass index, ethnicity/race, physical activity, hormonal contraceptive use, season of blood draw, use of analgesics, and calcium intake.

      Results

      Compared with participants with adequate vitamin D status, those with inadequate vitamin D status had an increased risk (odds ratio [OR]; 95% CI) of experiencing the following mild symptoms: confusion (OR=1.72; 95% CI, 1.14 to 2.59) and desire to be alone (OR=1.47; 95% CI; 1.03 to 2.10), as well as the following moderate/severe symptoms: cramps (OR=1.50; 95% CI, 1.02 to 2.21), fatigue (OR=1.51; 95% CI, 1.04 to 2.21), anxiety (OR=1.63; 95% CI, 1.02 to 2.63), confusion (OR=2.23; 95% CI, 1.18 to 4.21), and sexual desire (OR=1.65; 95% CI, 1.09 to 2.51). Vitamin D status was not associated with other premenstrual symptoms (acne, bloating, mood swings, increased appetite, headache, clumsiness, insomnia, depression, or nausea).

      Conclusion

      Findings suggest that inadequate vitamin D status may be associated with increased severity of some, but not all, premenstrual symptoms.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Academy of Nutrition and Dietetics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Biggs W.S.
        • Demuth R.H.
        Premenstrual syndrome and premenstrual dysphoric disorder.
        Am Fam Physician. 2011; 84: 918-924
        • Braverman P.K.
        Premenstrual syndrome and premenstrual dysphoric disorder.
        J Pediatr Adolesc Gynecol. 2007; 20: 3-12
        • Yonkers K.A.
        • O'Brien P.M.
        • Eriksson E.
        Premenstrual syndrome.
        Lancet. 2008; 371: 1200-1210
        • Dennerstein L.
        • Lehert P.
        • Heinemann K.
        Epidemiology of premenstrual symptoms and disorders.
        Menopause Int. 2012; 18: 48-51
        • Hashemi S.
        • Ramezani Tehrani F.
        • Mohammadi N.
        • et al.
        Comparison of metabolic and hormonal profiles of women with and without premenstrual syndrome: A community based cross-sectional study.
        Int J Endocrinol Metab. 2016; 14e28422
        • Jarosz A.C.
        • Jamnik J.
        • El-Sohemy A.
        Hormonal contraceptive use and prevalence of premenstrual symptoms in a multiethnic Canadian population.
        BMC Womens Health. 2017; 17: 87
        • El-Lithy A.
        • El-Mazny A.
        • Sabbour A.
        • El-Deeb A.
        Effect of aerobic exercise on premenstrual symptoms, haematological and hormonal parameters in young women.
        J Obstet Gynaecol. 2015; 35: 389-392
        • Bertone-Johnson E.R.
        • Hankinson S.E.
        • Bendich A.
        • Johnson S.R.
        • Willett W.C.
        • Manson J.E.
        Calcium and vitamin D intake and risk of incident premenstrual syndrome.
        Arch Intern Med. 2005; 165: 1246-1252
        • Bertone-Johnson E.R.
        • Chocano-Bedoya P.O.
        • Zagarins S.E.
        • Micka A.E.
        • Ronnenberg A.G.
        Dietary vitamin D intake, 25-hydroxyvitamin D3 levels and premenstrual syndrome in a college-aged population.
        J Steroid Biochem Mol Biol. 2010; 121: 434-437
        • Tartagni M.
        • Cicinelli M.V.
        • Tartagni M.V.
        • et al.
        Vitamin D supplementation for premenstrual syndrome-related mood disorders in adolescents with severe hypovitaminosis D.
        J Pediatr Adolesc Gynecol. 2016; 29: 357-361
        • Rucker D.
        • Allan J.A.
        • Fick G.H.
        • Hanley D.A.
        Vitamin D insufficiency in a population of healthy western Canadians.
        CMAJ. 2002; 166: 1517-1524
        • Bertone-Johnson E.R.
        • Hankinson S.E.
        • Forger N.G.
        • et al.
        Plasma 25-hydroxyvitamin D and risk of premenstrual syndrome in a prospective cohort study.
        BMC Womens Health. 2014; 14: 56
        • Obeidat B.A.
        • Alchalabi H.A.
        • Abdul-Razzak K.K.
        • Al-Farras M.I.
        Premenstrual symptoms in dysmenorrheic college students: Prevalence and relation to vitamin D and parathyroid hormone levels.
        Int J Environ Res Public Health. 2012; 9: 4210-4222
        • Saeedian Kia A.
        • Amani R.
        • Cheraghian B.
        The association between the risk of premenstrual syndrome and vitamin D, calcium, and magnesium status among university students: A case control study.
        Health Promot Perspect. 2015; 5: 225-230
        • Rajaei S.
        • Akbari Sene A.
        • Norouzi S.
        • et al.
        The relationship between serum vitamin D level and premenstrual syndrome in Iranian women.
        Int J Reprod Biomed (Yazd). 2016; 14: 665-668
        • Halbreich U.
        • O'Brien P.M.
        • Eriksson E.
        • Backstrom T.
        • Yonkers K.A.
        • Freeman E.W.
        Are there differential symptom profiles that improve in response to different pharmacological treatments of premenstrual syndrome/premenstrual dysphoric disorder?.
        CNS Drugs. 2006; 20: 523-547
        • Garcia-Bailo B.
        • Jamnik J.
        • Da Costa L.A.
        • Badawi A.
        • El-Sohemy A.
        Genetic variation in the vitamin D receptor, plasma 25-hydroxyvitamin D, and biomarkers of cardiometabolic disease in Caucasian young adults.
        J Nutrigenet Nutrigenomics. 2013; 6: 256-267
        • Cahill L.E.
        • El-Sohemy A.
        Haptoglobin genotype modifies the association between dietary vitamin C and serum ascorbic acid deficiency.
        Am J Clin Nutr. 2010; 92: 1494-1500
        • Rapkin A.J.
        • Akopians A.L.
        Pathophysiology of premenstrual syndrome and premenstrual dysphoric disorder.
        Menopause Int. 2012; 18: 52-59
        • Garcia-Bailo B.
        • Karmali M.
        • Badawi A.
        • El-Sohemy A.
        Plasma 25-hydroxyvitamin D, hormonal contraceptive use, and cardiometabolic disease risk in an ethnically diverse population of young adults.
        J Am Coll Nutr. 2013; 32: 296-306
        • Bischoff-Ferrari H.A.
        • Giovannucci E.
        • Willett W.C.
        • Dietrich T.
        • Dawson-Hughes B.
        Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes.
        Am J Clin Nutr. 2006; 84: 18-28
        • Holick M.F.
        • Binkley N.C.
        • Bischoff-Ferrari H.A.
        • et al.
        Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline.
        J Clin Endocrinol Metab. 2011; 96: 1911-1930
        • Ross A.C.
        The 2011 report on dietary reference intakes for calcium and vitamin D.
        Public Health Nutr. 2011; 14: 938-939
        • Holmes M.D.
        • Powell I.J.
        • Campos H.
        • Stampfer M.J.
        • Giovannucci E.L.
        • Willett W.C.
        Validation of a food frequency questionnaire measurement of selected nutrients using biological markers in African-American men.
        Eur J Clin Nutr. 2007; 61: 1328-1336
        • Willett W.C.
        • Stampfer M.J.
        • Underwood B.A.
        • Speizer F.E.
        • Rosner B.
        • Hennekens C.H.
        Validation of a dietary questionnaire with plasma carotenoid and alpha-tocopherol levels.
        Am J Clin Nutr. 1983; 38: 631-639
        • Nutrient Data Laboratory (U.S.), Consumer and Food Economics Institute (U.S.)
        USDA nutrient database for standard reference.[database on CD-ROM].
        US Department of Agriculture, Nutrient Data Laboratory, Agricultural Research Service, Riverdale, MD1999 (CD-ROMs)
        • Paffenbarger Jr., R.S.
        • Blair S.N.
        • Lee I.M.
        • Hyde R.T.
        Measurement of physical activity to assess health effects in free-living populations.
        Med Sci Sports Exerc. 1993; 25: 60-70
      1. SAS Software [computer program]. Version 9.4. SAS Institute Inc., Cary, NC2013
      2. Institute of Medicine; Food and Nutrition Board; Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. IOM (Institute of Medicine). Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: The National Academies Press; 2011.

        • Hanley D.A.
        • Cranney A.
        • Jones G.
        • et al.
        Vitamin D in adult health and disease: A review and guideline statement from Osteoporosis Canada.
        CMAJ. 2010; 182: E610-E618
        • Thys-Jacobs S.
        • McMahon D.
        • Bilezikian J.P.
        Cyclical changes in calcium metabolism across the menstrual cycle in women with premenstrual dysphoric disorder.
        J Clin Endocrinol Metab. 2007; 92: 2952-2959
        • Thys-Jacobs S.
        • Alvir M.J.
        Calcium-regulating hormones across the menstrual cycle: Evidence of a secondary hyperparathyroidism in women with PMS.
        J Clin Endocrinol Metab. 1995; 80: 2227-2232
        • Thys-Jacobs S.
        • Starkey P.
        • Bernstein D.
        • Tian J.
        Calcium carbonate and the premenstrual syndrome: Effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group.
        Am J Obstet Gynecol. 1998; 179: 444-452
        • Thys-Jacobs S.
        Micronutrients and the premenstrual syndrome: The case for calcium.
        J Am Coll Nutr. 2000; 19: 220-227
        • Stewart A.
        • Wong K.
        • Cachat J.
        • et al.
        Neurosteroid vitamin D system as a nontraditional drug target in neuropsychopharmacology.
        Behav Pharmacol. 2010; 21: 420-426
        • Groves N.J.
        • McGrath J.J.
        • Burne T.H.
        Vitamin D as a neurosteroid affecting the developing and adult brain.
        Annu Rev Nutr. 2014; 34: 117-141
        • Eyles D.W.
        • Smith S.
        • Kinobe R.
        • Hewison M.
        • McGrath J.J.
        Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain.
        J Chem Neuroanat. 2005; 29: 21-30
        • Bertone-Johnson E.R.
        Vitamin D and the occurrence of depression: Causal association or circumstantial evidence?.
        Nutr Rev. 2009; 67: 481-492
        • Stumpf W.E.
        • Privette T.H.
        Light, vitamin D and psychiatry. Role of 1,25 dihydroxyvitamin D3 (soltriol) in etiology and therapy of seasonal affective disorder and other mental processes.
        Psychopharmacology (Berl). 1989; 97: 285-294
        • Hoogendijk W.J.
        • Lips P.
        • Dik M.G.
        • Deeg D.J.
        • Beekman A.T.
        • Penninx B.W.
        Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults.
        Arch Gen Psychiatry. 2008; 65: 508-512
        • Dadkhah H.
        • Ebrahimi E.
        • Fathizadeh N.
        Evaluating the effects of vitamin D and vitamin E supplement on premenstrual syndrome: A randomized, double-blind, controlled trial.
        Iran J Nurs Midwifery Res. 2016; 21: 159-164
        • Bahrami A.
        • Avan A.
        • Sadeghnia H.R.
        • et al.
        High dose vitamin D supplementation can improve menstrual problems, dysmenorrhea, and premenstrual syndrome in adolescents.
        Gynecol Endocrinol. 2018; 34: 659-663
        • Bertone-Johnson E.R.
        Chronic inflammation and premenstrual syndrome: A missing link found?.
        J Womens Health (Larchmt). 2016; 25: 857-858
        • Puder J.J.
        • Blum C.A.
        • Mueller B.
        • De Geyter C.
        • Dye L.
        • Keller U.
        Menstrual cycle symptoms are associated with changes in low-grade inflammation.
        Eur J Clin Invest. 2006; 36: 58-64
        • Bertone-Johnson E.R.
        • Ronnenberg A.G.
        • Houghton S.C.
        • et al.
        Association of inflammation markers with menstrual symptom severity and premenstrual syndrome in young women.
        Hum Reprod. 2014; 29: 1987-1994
        • Gold E.B.
        • Wells C.
        • Rasor M.O.
        The Association of inflammation with premenstrual symptoms.
        J Womens Health (Larchmt). 2016; 25: 865-874
        • Bouillon R.
        • Carmeliet G.
        • Verlinden L.
        • et al.
        Vitamin D and human health: Lessons from vitamin D receptor null mice.
        Endocr Rev. 2008; 29: 726-776
        • Lagishetty V.
        • Liu N.Q.
        • Hewison M.
        Vitamin D metabolism and innate immunity.
        Mol Cell Endocrinol. 2011; 347: 97-105
        • Willett W.
        Nutritional epidemiology.
        3rd edition. Monographs in Epidemiology and Biostatistics. Vol 40. Oxford University Press, New York, NY2013

      Biography

      A. C. Jarosz is a medical student, University of Alberta, Edmonton, Alberta, Canada; at the time of the study, she was a master's candidate, Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

      Biography

      A. El-Sohemy is a professor, Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.